Skip to main content
OpenTrials
Completed

NCT Number: NCT04561973

Pain in Patients With Cystic Fibrosis in Rouen University Hospital

Objectif Principal

- To evaluate the intensity and frequency of pain episodes in patients with cystic fibrosis followed at the cystic fibrosis center of Rouen University Hospital, Normandy, France.

Objectifs secondaires

* To assess the relationship between pain and disease severity. * To assess the relationship between pain and the age of the patient. * To describe the pain locations. * To describe the use of pharmacological or nonpharmacological treatment. * To evaluate the procedural pain.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Patients seen for routine planned visits complete a self-administered retrospective questionnaire about pain during the last 3 months, and a prospective diary during the two weeks following the visit.

Primary evaluation criteria :

Intensity and frequency of pain are evaluated with the prospective diary.

  • The pain intensity is assessed by validated scales adapted to the patient's age (scale ranging from 0 to 10).

0 to 6 years : numerical rating scale assessed by the parents. 4 to 7 years : Faces Pain Scale Revised. Children 6 years and older, adolescents and adults: numerical rating scale self-reported

  • The pain frequency is completed twice a day (morning and evening) on the prospective pain diary.

Secondary evaluation criteria

  • The disease severity, estimated using recent forced expiratory volume in one second (FEV1) (best measurement of the year before bronchodilator, collected in the patient's medical record)
  • Pain locations, pharmacological or nonpharmacological treatment and procedural pain are evaluated using the diary and the questionnaire.
  • Demographic data and characteristics of cystic fibrosis are collected using the medical file.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children and adults followed at the cystic fibrosis center of Rouen University Hospital, Normandy, France.
  • Seen for routine planned visits.
  • Having expressed their non-opposition or whose non-opposition was expressed by the parents or legal representatives for minors

Exclusion criteria

  • Patients seen for an acute episode or exacerbation outside of routine planned visits or patient hospitalized.
  • Major patient under legal protection.
  • Major patient having problems understanding the oral and written French language or child whose parents or legal representatives have problems understanding the oral and written French language.

Treatment and study plan

numerical rating scale

Behavioral

Patients seen for routine planned visits complete a self-administered retrospective questionnaire about pain during the last 3 months, and a prospective diary during the two weeks following the visit.

Primary outcomes

  1. To evaluate the intensity and frequency of pain episodes in patients with cystic fibrosis followed at the cystic fibrosis center of Rouen University Hospital, Normandy, France

    Time frame: 14 days

    Intensity and frequency of pain are evaluated with the prospective diary. The pain intensity is assessed by validated scales adapted to the patient's age (scale ranging from 0 to 10).

    0 to 6 years : numerical rating scale assessed by the parents. 4 to 7 years : Faces Pain Scale Revised. Children 6 years and older, adolescents and adults: numerical rating scale self-reported The pain frequency is completed twice a day (morning and evening) on the prospective pain diary.

Secondary outcomes

  1. To assess the correlation between pain and disease severity

    Time frame: 14 days

    The disease severity is estimated using recent forced expiratory volume in one second (FEV1) (best measurement of the year before bronchodilator), collected in the patient's medical record. The correlation between pain and the disease severity will be studied with a Spearman's correlation coefficient.

  2. To assess the correlation between pain and the age of the patient.

    Time frame: 14 days

    Age of the patient is collected using the medical file. The correlation between pain and the age will be studied with a Spearman's correlation coefficient.

  3. To describe the pain locations.

    Time frame: 14 days

    Pain locations are evaluated using the prospective diary and the self-administered retrospective questionnaire.

  4. To describe the use of pharmacological or nonpharmacological treatment.

    Time frame: 14 days

    The pharmacological or nonpharmacological treatments are evaluated using the prospective diary (did you take a treatment for that pain episode ?) and the self-administered retrospective questionnaire. The efficacity of the treatment is evaluated with the diary (relief or not) et the questionnaire (Likert-type rating scale : Always, often, rarely, never).

  5. To evaluate the procedural pain.

    Time frame: 3 months

    The procedural pain and the proposed pain treatment are evaluated using the self-administered retrospective questionnaire.

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Acronym: MUCODOL

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Sep 24, 2020
Registry last updated
Feb 21, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.